Long term benefit of Dual Immunotherapy in Advanced Hepatocellular Carcinoma: 4 year OS data of the HIMALAYA study
January 25, 2024
HSP in partnership with AstraZeneca invites you to a webinar on January 25, 2024 – 6pm
Long term benefit of Dual Immunotherapy in Advanced Hepatocellular Carcinoma: 4 year OS data of the HIMALAYA study
Speaker: Dr. Eternity Labio
Moderator: Dr. Jade Jamias
To join, please click the zoom link:
https://astrazeneca.zoom.us/j/7754115455?pwd=R3o1TU91TnZFTy9VczdNTjltTnFkQT09&omn=94286417513
Meeting ID: 775 411 5455
Password: AZONCO
